Gadolinium is used because it creates a distinct contrast between a patient’s blood vessels and surrounding tissues and organs as they are viewed on an MRI or sometimes an MRA. This contrast allows doctors to see the patient’s internal structures much more clearly, helping to avoid potential mistakes or omissions. In recent years, however, serious problems have arisen involving the use of gadolinium in patients who have kidney problems or renal disease. When gadolinium is injected into an otherwise-healthy patient, it is generally is eliminated by the kidneys after the examination, and does not cause problems. Those with kidney problems, however, may be unable to expel the substance from their systems resulting in the prolonged exposure to the agent within their bodies which can result in the development of Nephrogenic Systemic Fibrosis (NSF), also known as Nephrogrenic Fibrosing Dermopathy (NFD). This progressive disorder can cause fibrosis, or scarring, of the skin and internal organs. The results of these disorders lead to thick, coarse and hard skin which severely restricts movement of the joints. There is no known cure for these disorders, and they can lead to patients being bound to a wheelchair and even death. In 2006, the FDA issued a warning in this regard. If you or a loved one has been injured as a result of gadolinium, please contact the gadolinium attorney Michael C. Watson, Attorney at Law, today for a free consultation.